The lincRNA HOTAIRM1, located in the HOXA genomic region, is expressed in acute myeloid leukemia, impacts prognosis in patients in the intermediate-risk cytogenetic category, and is associated with a distinctive microRNA signature

Autor: Díaz-Beyá, Marina, Brunet Mauri, Maria Salut, Nomdedeu, Josep, Pratcorona, Marta, Cordeiro, Anna, Gallardo, David, Escoda, Lourdes, Tormo, Mar, Heras, Inmaculada, Ribera, Jose-Maria, Duarte, Rafael, Llano Queipo, María Paz de, Bargay, Joan, Sampol, Antonia, Nomdedeu, Meritxell, Risueño, Ruth M., Hoyos Colell, Montserrat, Sierra Gil, Jorge, Monzo, Mariano, Navarro, Alfons, Esteve Reyner, Jordi, Cooperative AML group CETLAM, Universitat Autònoma de Barcelona

Publikováno v: Oncotarget
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Europe PubMed Central
Dipòsit Digital de la UB
Universidad de Barcelona
Recercat. Dipósit de la Recerca de Catalunya
Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona

Long non-coding RNAs (lncRNAs) are deregulated in several tumors, although their role in acute myeloid leukemia (AML) is mostly unknown. We have examined the expression of the lncRNA HOX antisense intergenic RNA myeloid 1 (HOTAIRM1) in 241 AML patien

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::363669f60cd22dc578629ec6036d0e3e
https://www.scopus.com/inward/record.uri?eid=2-s2.0-84945568293&doi=10.18632/oncotarget.5148&partnerID=40&md5=52230923b31c155eb0df41820cea86be